{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:58:54Z","timestamp":1760889534898},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T00:00:00Z","timestamp":1515369600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10067-017-3956-3","type":"journal-article","created":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T23:58:06Z","timestamp":1515369486000},"page":"917-925","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MRI assessment of erosion repair in patients with long-standing rheumatoid arthritis receiving double-filtration plasmapheresis in addition to leflunomide and methotrexate: a randomized controlled trial"],"prefix":"10.1007","volume":"37","author":[{"given":"Xiaoxia","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guobin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,8]]},"reference":[{"issue":"4","key":"3956_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D, T2T Expert Committee (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631\u2013637. \nhttps:\/\/doi.org\/10.1136\/ard.2009.123919","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3956_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/ard.2006.057497","volume":"66","author":"G Cohen","year":"2007","unstructured":"Cohen G, Gossec L, Dougados M, Cantagrel A, Goupille P, Daures JP, Rincheval N, Combe B (2007) Radiological damage in patients with rheumatoid arthritis on sustained remission. Ann Rheum Dis 66(3):358\u2013363. \nhttps:\/\/doi.org\/10.1136\/ard.2006.057497","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3956_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/art.11481","volume":"50","author":"ET Molenaar","year":"2004","unstructured":"Molenaar ET, Voskuy AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA (2004) Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 50(1):36\u201342. \nhttps:\/\/doi.org\/10.1002\/art.11481","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3956_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/039463200902200221","volume":"22","author":"B Lagan\u00e0","year":"2009","unstructured":"Lagan\u00e0 B, Picchianti Diamanti A, Ferlito C, Germano V, Migliore A, Cremona A, Argento G, David V, Salemi S, D\u2019Amelio R (2009) Imaging progression despite clinical remission in early rheumatoid arthritis patients after etanercept interruption. Int J Immunopathol Pharmacol 22(2):447\u2013454. \nhttps:\/\/doi.org\/10.1177\/039463200902200221","journal-title":"Int J Immunopathol Pharmacol"},{"key":"3956_CR5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/ard.2008.092254","volume":"68","author":"SM Kooij van der","year":"2009","unstructured":"van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, G\u00fcler-Y\u00fcksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF (2009) Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis 68:914\u2013921","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3956_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/03009742.2015.1070902","volume":"45","author":"K Forslind","year":"2016","unstructured":"Forslind K, Svensson B (2016) MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis. Scand J Rheumatol 45(2):99\u2013102. \nhttps:\/\/doi.org\/10.3109\/03009742.2015.1070902","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"3956_CR7","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1002\/art.23945","volume":"58","author":"AK Brown","year":"2008","unstructured":"Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P (2008) An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 58(10):2958\u20132967. \nhttps:\/\/doi.org\/10.1002\/art.23945","journal-title":"Arthritis Rheum"},{"issue":"12","key":"3956_CR8","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1002\/art.22190","volume":"54","author":"AK Brown","year":"2006","unstructured":"Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, Wakefield RJ, O\u2019Connor PJ, Emery P (2006) Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 54(12):3761\u20133773. \nhttps:\/\/doi.org\/10.1002\/art.22190","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3956_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/art.38307","volume":"66","author":"J Sokolove","year":"2014","unstructured":"Sokolove J, Johnson DS, Lahey LJ, Wagner CA, Cheng D, Thiele GM, Michaud K, Sayles H, Reimold AM, Caplan L, Cannon GW, Kerr G, Mikuls TR, Robinson WH (2014) Rheumatoid factor as a potentiator of anti-citrullinated protein antibody mediated inflammation in rheumatoid arthritis. Arthritis Rheumatol 66(4):813\u2013821. \nhttps:\/\/doi.org\/10.1002\/art.38307","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"3956_CR10","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1136\/annrheumdis-2014-205428","volume":"74","author":"C Hecht","year":"2015","unstructured":"Hecht C, Englbrecht M, Rech J, Schmidt S, Araujo E, Engelke K, Finzel S, Schett G (2015) Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis 74(12):2151\u20132156. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2014-205428","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3956_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1136\/annrheumdis-2015-207326","volume":"75","author":"JH Humphreys","year":"2016","unstructured":"Humphreys JH, Verheul MK, Barton A, MacGregor AJ, Lunt M, Toes REM, Symmons DPM, Trouw LA, Verstappen SMM (2016) Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk arthritis register. Ann Rheum Dis 75(6):1139\u20131144. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2015-207326","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"3956_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/ard.2003.016808","volume":"63","author":"A Kastbom","year":"2004","unstructured":"Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63(9):1085\u20131089. \nhttps:\/\/doi.org\/10.1136\/ard.2003.016808","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3956_CR13","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00296-015-3271-8","volume":"35","author":"W Katchamart","year":"2015","unstructured":"Katchamart W, Koolvisoot A, Aromdee E, Chiowchanwesawakit P, Muengchan C (2015) Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Rheumatol Int 35(10):1693\u20131699. \nhttps:\/\/doi.org\/10.1007\/s00296-015-3271-8","journal-title":"Rheumatol Int"},{"issue":"5","key":"3956_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/rheumatology\/keg184","volume":"42","author":"S Bas","year":"2003","unstructured":"Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42(5):677\u2013680. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/keg184","journal-title":"Rheumatology"},{"issue":"2","key":"3956_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/annrheumdis-2014-205698","volume":"75","author":"A Kastbom","year":"2016","unstructured":"Kastbom A, Forslind K, Ernestam S, Geborek P, Karlsson JA, Petersson IF, Saevarsdottir S, Klareskog L, van Vollenhoven RF, Lundberg K (2016) Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial. Ann Rheum Dis 75(2):356\u2013361. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2014-205698","journal-title":"Ann Rheum Dis"},{"key":"3956_CR16","unstructured":"Ismail N, Neyra R, Hakim RM(2001) Plasmapheresis. In: Daugirdas JT, Blake PG, Ing TS(ed) handbook of dialysis, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp231\u2013262"},{"key":"3956_CR17","doi-asserted-by":"crossref","unstructured":"Zhang Y-y, Zheng T, Chen D-m, Gong D-h, Ji D-x, Liu Z-h (2014) Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis. BMC Nephrol 315(128)","DOI":"10.1186\/1471-2369-15-128"},{"issue":"3","key":"3956_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324. \nhttps:\/\/doi.org\/10.1002\/art.1780310302","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3956_CR19","first-page":"1385","volume":"30","author":"M \u00d8stergaard","year":"2003","unstructured":"\u00d8stergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, Shnier R, O'Connor P, Klarlund M, Emery P, Genant H, Lassere M, Edmonds J (2003) OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 30(6):1385\u20131386","journal-title":"J Rheumatol"},{"key":"3956_CR20","doi-asserted-by":"crossref","unstructured":"Prevoo ML, van Gestel AM, van T Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. (1996)Remission in a prospective study of patients with rheumatoid arthritis: American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 35:1101\u20131105, 11","DOI":"10.1093\/rheumatology\/35.11.1101"},{"issue":"6","key":"3956_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/art.1780380602","volume":"38","author":"DT Felson","year":"1995","unstructured":"Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V et al (1995) American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38(6):727\u2013735. \nhttps:\/\/doi.org\/10.1002\/art.1780380602","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3956_CR22","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/1529-0131(199809)41:9<1564::AID-ART6>3.0.CO;2-M","volume":"41","author":"DT Felson","year":"1998","unstructured":"Felson DT, Anderson JJ, Lange ML, Wells G, LaValley MP (1998) Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum 41(9):1564\u20131570. \nhttps:\/\/doi.org\/10.1002\/1529-0131(199809)41:9<1564::AID-ART6>3.0.CO;2-M","journal-title":"Arthritis Rheum"},{"key":"3956_CR23","unstructured":"Haijun Zhang, Sizeng Zhang, Xing Lin, Ming Jiang (2004) Treatment of rheumatoid arthritis. In: Ming Jiang, DAVID Yu, Xiaoyi Lin (ed) Rheumatology, first edn. Huaxia, Beijing, pp771\u2013827"},{"issue":"1","key":"3956_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/annrheumdis-2014-206015","volume":"75","author":"C Peterfy","year":"2016","unstructured":"Peterfy C, Emery P, Tak PP, \u00d8stergaard M, DiCarlo J, Otsa K, Sarabia FN, Pavelka K, Bagnard M-A, Gylvin LH, Bernasconi C, Gabriele A (2016) MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study. Ann Rheum Dis 75(1):170\u2013177. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2014-206015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3956_CR25","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/annrheumdis-2013-204537","volume":"74","author":"MB Axelsen","year":"2015","unstructured":"Axelsen MB, Eshed H-PK, Stengaard-Pedersen K, Hetland ML, M\u00f8ller J, Junker P, P\u00f8denphant J, Schlemmer A, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Dam MY, Hansen I, Horn HC, Ammitzb\u00f8ll CG, J\u00f8rgensen A, Krintel SB, Raun J, Krogh NS, Johansen JS, \u00d8stergaard M, OPERA study group (2015) A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial. Ann Rheum Dis 74(5):867\u2013875. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2013-204537","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3956_CR26","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/annrheumdis-2013-204762","volume":"73","author":"PG Conaghan","year":"2014","unstructured":"Conaghan PG, Peterfy C, Olech E, Kaine J, Ridley D, DiCarlo J, Friedman J, Devenport J, Troum O (2014) The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy. Ann Rheum Dis 73(5):810\u2013816. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2013-204762","journal-title":"Ann Rheum Dis"},{"key":"3956_CR27","unstructured":"DUMMY"},{"issue":"11","key":"3956_CR28","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1136\/ard.2010.146068","volume":"70","author":"PG Conaghan","year":"2011","unstructured":"Conaghan PG, Emery P, \u00d8stergaard M, Keystone EC, Genovese MC, Hsia EC, Xu W, Rahman MU (2011) Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial. Ann Rheum Dis 70(11):1968\u20131974. \nhttps:\/\/doi.org\/10.1136\/ard.2010.146068","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3956_CR29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/annrheumdis-2012-201611","volume":"72","author":"PG Conaghan","year":"2013","unstructured":"Conaghan PG, Durez P, Alten RE, Burmester GR, Tak PP, Klareskog L, Catrina AI, DiCarlo J, Gaillez C, Le Bars M, Zhou X, Peterfy C (2013) Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial. Ann Rheum Dis 72(8):1287\u20131294. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2012-201611","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3956_CR30","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1002\/art.23055","volume":"56","author":"P Durez","year":"2007","unstructured":"Durez P, Malghem J, Nzeusseu Toukap A, Depresseux G, Lauwerys BR, Westhovens R, Luyten FP, Corluy L, Houssiau FA, Verschueren P (2007) Treatment of early rheumatoid arthritis. A randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. ARTHRITIS RHEUM 56(12):3919\u20133927. \nhttps:\/\/doi.org\/10.1002\/art.23055","journal-title":"ARTHRITIS RHEUM"},{"issue":"4","key":"3956_CR31","first-page":"584","volume":"35","author":"M Boesen","year":"2008","unstructured":"Boesen M, Boesen L, Jensen KE, Cimmino MA, Torp-Pedersen S, Terslev L, Koenig M, Danneskiold-Sams\u00f8e B, R\u00f8gind H, Bliddal H (2008) Clinical outcome and imaging changes after intraarticular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks. J Rheumatol 35(4):584\u2013591","journal-title":"J Rheumatol"},{"issue":"6","key":"3956_CR32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3899\/jrheum.110978","volume":"39","author":"X Yu","year":"2012","unstructured":"Yu X, Wang L, Xu P, Lu W, Lan G, Ping L, Wang X, Tian J, Liu J (2012) Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis. J Rheumatol 39(6):1171\u20131178. \nhttps:\/\/doi.org\/10.3899\/jrheum.110978","journal-title":"J Rheumatol"},{"issue":"1","key":"3956_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13075-016-1076-0","volume":"18","author":"DM Boeters","year":"2016","unstructured":"Boeters DM, Nieuwenhuis WP, Verheul MK, Newsum EC, Reijnierse M, Toes REM, Trouw LA, van der Helm-van Mil AHM (2016) MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF. Arthritis Res Ther 18(1):179. \nhttps:\/\/doi.org\/10.1186\/s13075-016-1076-0","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3956_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10067-009-1337-2","volume":"29","author":"H Li","year":"2010","unstructured":"Li H, Song W, Li Y, Liu Y, Bai J, Li X, Mu F, Wang Y, Zhang F, Su L (2010) Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin Rheumatol 29(4):413\u2013417. \nhttps:\/\/doi.org\/10.1007\/s10067-009-1337-2","journal-title":"Clin Rheumatol"},{"issue":"1","key":"3956_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/ard.2005.04138","volume":"65","author":"M Tamai","year":"2006","unstructured":"Tamai M, Kawakami A, Uetani M, Takao S, Tanaka F, Nakamura H, Iwanaga N, Izumi Y, Arima K, Aratake K, Kamachi M, Huang M, Origuchi T, Ida H, Aoyagi K, Eguchi K (2006) The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis. Ann Rheum Dis 65(1):133\u2013134. \nhttps:\/\/doi.org\/10.1136\/ard.2005.04138","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3956_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10067-011-1820-4","volume":"31","author":"Y Yacoub Ibn","year":"2012","unstructured":"Ibn Yacoub Y, Amine B, Laatiris A, Hajjaj-Hassouni N (2012) Rheumatoid factor and antibodies against citrullinated peptides in Moroccan patients with rheumatoid arthritis: association with disease parameters and quality of life. Clin Rheumatol 31(2):329\u2013334. \nhttps:\/\/doi.org\/10.1007\/s10067-011-1820-4","journal-title":"Clin Rheumatol"},{"issue":"1","key":"3956_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/annrheumdis-2015-208870","volume":"76","author":"S Ajeganova","year":"2017","unstructured":"Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafstr\u00f6m I, Toes RE, Huizinga TW, Svensson B, Trouw LA, van der Helm-van Mil AH (2017) The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor. Ann Rheum Dis 76(1):112\u2013118. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2015-208870","journal-title":"Ann Rheum Dis"},{"issue":"1\u20132","key":"3956_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12026-014-8560-x","volume":"61","author":"A Yee","year":"2015","unstructured":"Yee A, Webb T, Seaman A, Infantino M, Meacci F, Manfredi M, Benucci M, Lakos G, Favalli E, Schioppo T, Meroni PL, Mahler M (2015) Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Immunol Res 61(1\u20132):24\u201330. \nhttps:\/\/doi.org\/10.1007\/s12026-014-8560-x","journal-title":"Immunol Res"},{"issue":"10055","key":"3956_CR39","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, Mc Innes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"issue":"9","key":"3956_CR40","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s10067-016-3280-3","volume":"35","author":"L Li","year":"2016","unstructured":"Li L, Wen W, Jia R, Li Y, Liu X, Sun X, Li Z (2016) GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis. Clin Rheumatol 35(9):2195\u20132202. \nhttps:\/\/doi.org\/10.1007\/s10067-016-3280-3","journal-title":"Clin Rheumatol"},{"key":"3956_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cca.2016.02.010","volume":"455","author":"S Mateen","year":"2016","unstructured":"Mateen S, Zafar A, Moin S, Khan AQ, Zubair S (2016) Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clin Chim Acta 455:161\u2013171. \nhttps:\/\/doi.org\/10.1016\/j.cca.2016.02.010","journal-title":"Clin Chim Acta"},{"issue":"4","key":"3956_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00281-017-0627-z","volume":"39","author":"VFAM Derksen","year":"2017","unstructured":"Derksen VFAM, Huizinga TWJ, van der Woude D (2017) The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol 39(4):437\u2013446. \nhttps:\/\/doi.org\/10.1007\/s00281-017-0627-z","journal-title":"Semin Immunopathol"},{"issue":"4","key":"3956_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/RHU.0b013e318124a483","volume":"13","author":"X Yu","year":"2007","unstructured":"Yu X, Ma J, Tian J, Jiang S, Xu P, Han H, Wang L (2007) A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis. J Clin Rheumatol 13(4):193\u2013198. \nhttps:\/\/doi.org\/10.1097\/RHU.0b013e318124a483","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"3956_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/1744-9987.12389","volume":"20","author":"Y Chen","year":"2016","unstructured":"Chen Y, Yang L, Li K, Liu Z, Gong D, Zhang H, Liu Z, Hu W (2016) Double filtration plasmapheresis in the treatment of antineutrophil cytoplasmic autoantibody associated vasculitis with severe renal failure: a preliminary study of 15 patients. Ther Apher Dial 20(2):183\u2013188. \nhttps:\/\/doi.org\/10.1111\/1744-9987.12389","journal-title":"Ther Apher Dial"},{"issue":"1","key":"3956_CR45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1744-9987.2012.01107.x","volume":"17","author":"D Gong","year":"2013","unstructured":"Gong D, Ji D, Xu B, Liu Z (2013) More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy. Ther Apher Dial 17(1):93\u201398. \nhttps:\/\/doi.org\/10.1111\/j.1744-9987.2012.01107.x","journal-title":"Ther Apher Dial"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3956-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3956-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3956-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T08:59:53Z","timestamp":1522659593000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3956-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3956"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3956-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,8]]}}}